Screen misuse blamed for painful 'tech neck' problems
The 25-year-old, who works in corporate hospitality, is constantly surrounded by screens, both at work and in her personal life.
Women are the primary sufferers of neck pain across nearly all age groups, except those aged 51 to 60, research reveals.
Dubbed 'tech neck', the condition stems from the misuse of technology, with women being particularly vulnerable to its debilitating effects.
Ms Champion said her discomfort worsened over years of technology use, with pain radiating from her back into her head.
"There was a ripple on effect with work, my social life and the way I interacted with my family and friends, all because of the pain," she told AAP.
An Australian Chiropractors Association survey found 68 per cent of women experience neck pain, compared to 60 per cent of men.
Despite the high prevalence of neck pain, about two out of five sufferers did not consult a healthcare practitioner, while little more than a quarter sought a formal diagnosis.
Instead, the vast majority (78 per cent) used over-the-counter pain relief for neck pain.
"I was really reliant on over the counter medications. It became the only defence against the sort of tension that I was feeling in my neck," Ms Champion said.
The Sydneysider started seeking chiropractic care when she was 22, and noticed a difference after four sessions.
"I learned the strategies to interact with technology in a healthy way," she said.
"It was postural correction techniques and easy behaviours that I could change. Even holding my phone at eye level made a dramatic impact."
The survey revealed proper posture, regular breaks, and correct ergonomics significantly reduced neck-pain prevalence.
Dr Kim Lie Jom, a chiropractor with 30 years of experience, said he was seeing a growing number of patients with technology-related injuries.
He believes the number of people suffering from tech neck is much higher than reported, describing the survey results as staggering.
"The survey showed during COVID-19 cases of children and teens experiencing neck pain surged," he told AAP.
"If this trend continues, the implications into the future would be quite dramatic."
With millions of Australians affected by neck pain, health bodies including the Australian Chiropractors Association are urging action to prevent tech neck across all ages.
For five years, Naoise Champion endured painful headaches and neck cramps, unaware the source of her discomfort was in her hand.
The 25-year-old, who works in corporate hospitality, is constantly surrounded by screens, both at work and in her personal life.
Women are the primary sufferers of neck pain across nearly all age groups, except those aged 51 to 60, research reveals.
Dubbed 'tech neck', the condition stems from the misuse of technology, with women being particularly vulnerable to its debilitating effects.
Ms Champion said her discomfort worsened over years of technology use, with pain radiating from her back into her head.
"There was a ripple on effect with work, my social life and the way I interacted with my family and friends, all because of the pain," she told AAP.
An Australian Chiropractors Association survey found 68 per cent of women experience neck pain, compared to 60 per cent of men.
Despite the high prevalence of neck pain, about two out of five sufferers did not consult a healthcare practitioner, while little more than a quarter sought a formal diagnosis.
Instead, the vast majority (78 per cent) used over-the-counter pain relief for neck pain.
"I was really reliant on over the counter medications. It became the only defence against the sort of tension that I was feeling in my neck," Ms Champion said.
The Sydneysider started seeking chiropractic care when she was 22, and noticed a difference after four sessions.
"I learned the strategies to interact with technology in a healthy way," she said.
"It was postural correction techniques and easy behaviours that I could change. Even holding my phone at eye level made a dramatic impact."
The survey revealed proper posture, regular breaks, and correct ergonomics significantly reduced neck-pain prevalence.
Dr Kim Lie Jom, a chiropractor with 30 years of experience, said he was seeing a growing number of patients with technology-related injuries.
He believes the number of people suffering from tech neck is much higher than reported, describing the survey results as staggering.
"The survey showed during COVID-19 cases of children and teens experiencing neck pain surged," he told AAP.
"If this trend continues, the implications into the future would be quite dramatic."
With millions of Australians affected by neck pain, health bodies including the Australian Chiropractors Association are urging action to prevent tech neck across all ages.
For five years, Naoise Champion endured painful headaches and neck cramps, unaware the source of her discomfort was in her hand.
The 25-year-old, who works in corporate hospitality, is constantly surrounded by screens, both at work and in her personal life.
Women are the primary sufferers of neck pain across nearly all age groups, except those aged 51 to 60, research reveals.
Dubbed 'tech neck', the condition stems from the misuse of technology, with women being particularly vulnerable to its debilitating effects.
Ms Champion said her discomfort worsened over years of technology use, with pain radiating from her back into her head.
"There was a ripple on effect with work, my social life and the way I interacted with my family and friends, all because of the pain," she told AAP.
An Australian Chiropractors Association survey found 68 per cent of women experience neck pain, compared to 60 per cent of men.
Despite the high prevalence of neck pain, about two out of five sufferers did not consult a healthcare practitioner, while little more than a quarter sought a formal diagnosis.
Instead, the vast majority (78 per cent) used over-the-counter pain relief for neck pain.
"I was really reliant on over the counter medications. It became the only defence against the sort of tension that I was feeling in my neck," Ms Champion said.
The Sydneysider started seeking chiropractic care when she was 22, and noticed a difference after four sessions.
"I learned the strategies to interact with technology in a healthy way," she said.
"It was postural correction techniques and easy behaviours that I could change. Even holding my phone at eye level made a dramatic impact."
The survey revealed proper posture, regular breaks, and correct ergonomics significantly reduced neck-pain prevalence.
Dr Kim Lie Jom, a chiropractor with 30 years of experience, said he was seeing a growing number of patients with technology-related injuries.
He believes the number of people suffering from tech neck is much higher than reported, describing the survey results as staggering.
"The survey showed during COVID-19 cases of children and teens experiencing neck pain surged," he told AAP.
"If this trend continues, the implications into the future would be quite dramatic."
With millions of Australians affected by neck pain, health bodies including the Australian Chiropractors Association are urging action to prevent tech neck across all ages.
For five years, Naoise Champion endured painful headaches and neck cramps, unaware the source of her discomfort was in her hand.
The 25-year-old, who works in corporate hospitality, is constantly surrounded by screens, both at work and in her personal life.
Women are the primary sufferers of neck pain across nearly all age groups, except those aged 51 to 60, research reveals.
Dubbed 'tech neck', the condition stems from the misuse of technology, with women being particularly vulnerable to its debilitating effects.
Ms Champion said her discomfort worsened over years of technology use, with pain radiating from her back into her head.
"There was a ripple on effect with work, my social life and the way I interacted with my family and friends, all because of the pain," she told AAP.
An Australian Chiropractors Association survey found 68 per cent of women experience neck pain, compared to 60 per cent of men.
Despite the high prevalence of neck pain, about two out of five sufferers did not consult a healthcare practitioner, while little more than a quarter sought a formal diagnosis.
Instead, the vast majority (78 per cent) used over-the-counter pain relief for neck pain.
"I was really reliant on over the counter medications. It became the only defence against the sort of tension that I was feeling in my neck," Ms Champion said.
The Sydneysider started seeking chiropractic care when she was 22, and noticed a difference after four sessions.
"I learned the strategies to interact with technology in a healthy way," she said.
"It was postural correction techniques and easy behaviours that I could change. Even holding my phone at eye level made a dramatic impact."
The survey revealed proper posture, regular breaks, and correct ergonomics significantly reduced neck-pain prevalence.
Dr Kim Lie Jom, a chiropractor with 30 years of experience, said he was seeing a growing number of patients with technology-related injuries.
He believes the number of people suffering from tech neck is much higher than reported, describing the survey results as staggering.
"The survey showed during COVID-19 cases of children and teens experiencing neck pain surged," he told AAP.
"If this trend continues, the implications into the future would be quite dramatic."
With millions of Australians affected by neck pain, health bodies including the Australian Chiropractors Association are urging action to prevent tech neck across all ages.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Advertiser
19 hours ago
- The Advertiser
Mini hearts to save cancer survivors from heart disease
Breast cancer survivors at risk of severe heart disease due to chemotherapy and other treatments could benefit from a new drug to protect them from cardiovascular illness. In Australia, more than 21,000 people are diagnosed with breast cancer and about 3300 die from the disease each year. But the treatments helping patients survive chemotherapy and antibody-based therapies are also putting them at risk of heart failure, arrhythmias or other cardiovascular conditions years later. Heart disease related to cancer treatment is emerging as a significant threat to breast cancer survivors, with 30 per cent going on to develop potentially life-threatening heart complications. A team of scientists at the Heart Research Institute are using lab-grown "mini hearts" - the size of a grain of sand created from patient blood samples - to test drugs that could one day be given alongside chemotherapy. "We currently have limited knowledge on why cardiotoxicity occurs and which women will be most impacted," lead researcher Professor Julie McMullen said. "This research has the opportunity to identify women at risk of cardiotoxicity before symptoms are present, so we can develop drugs to protect the heart during and after cancer treatment." A protective drug would have been vital for Lee Hunt, who has experienced long-term heart damage from rounds of chemotherapy and Herceptin, a targeted therapy medication. "You never recover after cancer, but I was doing well until about five years after my treatment finished and I started experiencing dizzy spells," Ms Hunt told AAP. "It turned out the chemotherapy had affected my heart and I have permanent heart weakness. It won't kill me but it does need to be managed carefully. "Cancer treatment may save your life but that needs to be a good quality of life." The heart damage could sometimes be worse than the cancer itself, HRI research officer Dr Clara Liu Chung Ming said. "We want to give patients a therapy that can be safely delivered with their cancer treatment, to protect the heart before any damage occurs," she said. "It's about saving hearts as well as lives." While the research project is still in the pre-clinical stage, its potential is significant. The microscopic 3D "mini heart" models mimic aspects of how the human heart functions. "Our mini hearts replicate how a real heart contracts and responds to stress," Dr Liu Chung Ming said. "We expose them to chemotherapy and see how they react, then introduce our drug and see if it helps." The next step in the project will be to use breast cancer patient blood samples to generate personalised mini hearts. Breast cancer survivors at risk of severe heart disease due to chemotherapy and other treatments could benefit from a new drug to protect them from cardiovascular illness. In Australia, more than 21,000 people are diagnosed with breast cancer and about 3300 die from the disease each year. But the treatments helping patients survive chemotherapy and antibody-based therapies are also putting them at risk of heart failure, arrhythmias or other cardiovascular conditions years later. Heart disease related to cancer treatment is emerging as a significant threat to breast cancer survivors, with 30 per cent going on to develop potentially life-threatening heart complications. A team of scientists at the Heart Research Institute are using lab-grown "mini hearts" - the size of a grain of sand created from patient blood samples - to test drugs that could one day be given alongside chemotherapy. "We currently have limited knowledge on why cardiotoxicity occurs and which women will be most impacted," lead researcher Professor Julie McMullen said. "This research has the opportunity to identify women at risk of cardiotoxicity before symptoms are present, so we can develop drugs to protect the heart during and after cancer treatment." A protective drug would have been vital for Lee Hunt, who has experienced long-term heart damage from rounds of chemotherapy and Herceptin, a targeted therapy medication. "You never recover after cancer, but I was doing well until about five years after my treatment finished and I started experiencing dizzy spells," Ms Hunt told AAP. "It turned out the chemotherapy had affected my heart and I have permanent heart weakness. It won't kill me but it does need to be managed carefully. "Cancer treatment may save your life but that needs to be a good quality of life." The heart damage could sometimes be worse than the cancer itself, HRI research officer Dr Clara Liu Chung Ming said. "We want to give patients a therapy that can be safely delivered with their cancer treatment, to protect the heart before any damage occurs," she said. "It's about saving hearts as well as lives." While the research project is still in the pre-clinical stage, its potential is significant. The microscopic 3D "mini heart" models mimic aspects of how the human heart functions. "Our mini hearts replicate how a real heart contracts and responds to stress," Dr Liu Chung Ming said. "We expose them to chemotherapy and see how they react, then introduce our drug and see if it helps." The next step in the project will be to use breast cancer patient blood samples to generate personalised mini hearts. Breast cancer survivors at risk of severe heart disease due to chemotherapy and other treatments could benefit from a new drug to protect them from cardiovascular illness. In Australia, more than 21,000 people are diagnosed with breast cancer and about 3300 die from the disease each year. But the treatments helping patients survive chemotherapy and antibody-based therapies are also putting them at risk of heart failure, arrhythmias or other cardiovascular conditions years later. Heart disease related to cancer treatment is emerging as a significant threat to breast cancer survivors, with 30 per cent going on to develop potentially life-threatening heart complications. A team of scientists at the Heart Research Institute are using lab-grown "mini hearts" - the size of a grain of sand created from patient blood samples - to test drugs that could one day be given alongside chemotherapy. "We currently have limited knowledge on why cardiotoxicity occurs and which women will be most impacted," lead researcher Professor Julie McMullen said. "This research has the opportunity to identify women at risk of cardiotoxicity before symptoms are present, so we can develop drugs to protect the heart during and after cancer treatment." A protective drug would have been vital for Lee Hunt, who has experienced long-term heart damage from rounds of chemotherapy and Herceptin, a targeted therapy medication. "You never recover after cancer, but I was doing well until about five years after my treatment finished and I started experiencing dizzy spells," Ms Hunt told AAP. "It turned out the chemotherapy had affected my heart and I have permanent heart weakness. It won't kill me but it does need to be managed carefully. "Cancer treatment may save your life but that needs to be a good quality of life." The heart damage could sometimes be worse than the cancer itself, HRI research officer Dr Clara Liu Chung Ming said. "We want to give patients a therapy that can be safely delivered with their cancer treatment, to protect the heart before any damage occurs," she said. "It's about saving hearts as well as lives." While the research project is still in the pre-clinical stage, its potential is significant. The microscopic 3D "mini heart" models mimic aspects of how the human heart functions. "Our mini hearts replicate how a real heart contracts and responds to stress," Dr Liu Chung Ming said. "We expose them to chemotherapy and see how they react, then introduce our drug and see if it helps." The next step in the project will be to use breast cancer patient blood samples to generate personalised mini hearts. Breast cancer survivors at risk of severe heart disease due to chemotherapy and other treatments could benefit from a new drug to protect them from cardiovascular illness. In Australia, more than 21,000 people are diagnosed with breast cancer and about 3300 die from the disease each year. But the treatments helping patients survive chemotherapy and antibody-based therapies are also putting them at risk of heart failure, arrhythmias or other cardiovascular conditions years later. Heart disease related to cancer treatment is emerging as a significant threat to breast cancer survivors, with 30 per cent going on to develop potentially life-threatening heart complications. A team of scientists at the Heart Research Institute are using lab-grown "mini hearts" - the size of a grain of sand created from patient blood samples - to test drugs that could one day be given alongside chemotherapy. "We currently have limited knowledge on why cardiotoxicity occurs and which women will be most impacted," lead researcher Professor Julie McMullen said. "This research has the opportunity to identify women at risk of cardiotoxicity before symptoms are present, so we can develop drugs to protect the heart during and after cancer treatment." A protective drug would have been vital for Lee Hunt, who has experienced long-term heart damage from rounds of chemotherapy and Herceptin, a targeted therapy medication. "You never recover after cancer, but I was doing well until about five years after my treatment finished and I started experiencing dizzy spells," Ms Hunt told AAP. "It turned out the chemotherapy had affected my heart and I have permanent heart weakness. It won't kill me but it does need to be managed carefully. "Cancer treatment may save your life but that needs to be a good quality of life." The heart damage could sometimes be worse than the cancer itself, HRI research officer Dr Clara Liu Chung Ming said. "We want to give patients a therapy that can be safely delivered with their cancer treatment, to protect the heart before any damage occurs," she said. "It's about saving hearts as well as lives." While the research project is still in the pre-clinical stage, its potential is significant. The microscopic 3D "mini heart" models mimic aspects of how the human heart functions. "Our mini hearts replicate how a real heart contracts and responds to stress," Dr Liu Chung Ming said. "We expose them to chemotherapy and see how they react, then introduce our drug and see if it helps." The next step in the project will be to use breast cancer patient blood samples to generate personalised mini hearts.
The Advertiser
19 hours ago
- The Advertiser
Female-founded AI tool aims to transform women's health
Women are taking control of their health with a game-changing artificial intelligence tool to help navigate a medical system that has historically gaslit, dismissed and ignored their symptoms. More than half of Australian women live with a chronic health condition and wait years to be diagnosed, often as a result of being dismissed by health professionals. Mary Spanos first started experiencing painful symptoms of endometriosis when she was 12 years old but was not officially diagnosed until she was in her 20s. "It's a ridiculously long time to be experiencing those debilitating symptoms and there were countless emergency room visits and specialist appointments where I was completely dismissed," she tells AAP. Ms Spanos is one of countless women who have suffered in silence. "I honestly thought it was all in my head and had so many negative thoughts because the people who were supposed to know what was going on medically were telling me it was fine," she says. It's a similar story for Grace Lam, who started to experience debilitating health symptoms as she approached 50. A former senior fashion editor of Vogue China, Ms Lam was used to thriving in fast-paced, high-powered environments. Yet seemingly overnight, she began to experience insomnia, low libido, extreme brain fog and driving anxiety. "My symptoms hit me like a rocket overnight ... it felt like every day my brain was outside my body and I would wake up feeling so strange," Ms Lam says. "The rage was also something else. I am a feisty Asian woman, so that's nothing new, but this type of rage was just very different." When she raised these symptoms with her GP, the doctor prescribed her sleeping pills but would not discuss any management plans for perimenopause. "I didn't want to rely on the sleeping pills, so that's when I went down the rabbit hole of perimenopause symptoms online," Ms Lam says. "I learnt more about perimenopause online than from my doctor." A newly launched AI health partner Ovum wants to disrupt the health landscape and end gender health inequity across Australia. The app has been four years in the making, with two clinical trials at The Royal Hospital for Women and St George Hospital. It was founded by Ariella Heffernan-Marks, who had the idea while training as a doctor and witnessing the healthcare issues facing women. "I observed the structural barriers in our health care and realised we needed to look at integrated data rather than having it spread across multiple physicians and specialists," she says. "Women are feeling the bias in the healthcare system ... they have not been included in clinical trials for decades and this is impacting diagnostics and treatment." After suffering chronic migraines during medical school, Dr Heffernan-Marks personally experienced being dismissed by specialists and decided something needed to change. "We need to redefine women's health to not just be about reproductive health because there are so many chronic conditions facing women," she says. "All the fem-tech tools on the market are not catering to what women actually need." The AI behind Ovum draws from female-centric medical literature to understand and learn from a wide range of health factors. It helps identify patterns, log symptoms, collate reports and create questions for women to raise with their doctors at their next appointment. It is not a diagnostic tool but rather provides a starting point for discussion with a medical professional. Users can opt to share their information anonymously as part of a wider database researchers can use to develop new medications and treatments or better understand conditions. With access to sensitive personal data, Dr Heffernan-Marks says Ovum is nationally and globally compliant with stringent standards to protect users. "Ovum is really about addressing the structural, integrated and research barriers ... we have decades (of medical research) to catch up on and AI will help us do that," she says. "We are creating a safe space for women and solving the health data gap by feeding information back into the research." Women are taking control of their health with a game-changing artificial intelligence tool to help navigate a medical system that has historically gaslit, dismissed and ignored their symptoms. More than half of Australian women live with a chronic health condition and wait years to be diagnosed, often as a result of being dismissed by health professionals. Mary Spanos first started experiencing painful symptoms of endometriosis when she was 12 years old but was not officially diagnosed until she was in her 20s. "It's a ridiculously long time to be experiencing those debilitating symptoms and there were countless emergency room visits and specialist appointments where I was completely dismissed," she tells AAP. Ms Spanos is one of countless women who have suffered in silence. "I honestly thought it was all in my head and had so many negative thoughts because the people who were supposed to know what was going on medically were telling me it was fine," she says. It's a similar story for Grace Lam, who started to experience debilitating health symptoms as she approached 50. A former senior fashion editor of Vogue China, Ms Lam was used to thriving in fast-paced, high-powered environments. Yet seemingly overnight, she began to experience insomnia, low libido, extreme brain fog and driving anxiety. "My symptoms hit me like a rocket overnight ... it felt like every day my brain was outside my body and I would wake up feeling so strange," Ms Lam says. "The rage was also something else. I am a feisty Asian woman, so that's nothing new, but this type of rage was just very different." When she raised these symptoms with her GP, the doctor prescribed her sleeping pills but would not discuss any management plans for perimenopause. "I didn't want to rely on the sleeping pills, so that's when I went down the rabbit hole of perimenopause symptoms online," Ms Lam says. "I learnt more about perimenopause online than from my doctor." A newly launched AI health partner Ovum wants to disrupt the health landscape and end gender health inequity across Australia. The app has been four years in the making, with two clinical trials at The Royal Hospital for Women and St George Hospital. It was founded by Ariella Heffernan-Marks, who had the idea while training as a doctor and witnessing the healthcare issues facing women. "I observed the structural barriers in our health care and realised we needed to look at integrated data rather than having it spread across multiple physicians and specialists," she says. "Women are feeling the bias in the healthcare system ... they have not been included in clinical trials for decades and this is impacting diagnostics and treatment." After suffering chronic migraines during medical school, Dr Heffernan-Marks personally experienced being dismissed by specialists and decided something needed to change. "We need to redefine women's health to not just be about reproductive health because there are so many chronic conditions facing women," she says. "All the fem-tech tools on the market are not catering to what women actually need." The AI behind Ovum draws from female-centric medical literature to understand and learn from a wide range of health factors. It helps identify patterns, log symptoms, collate reports and create questions for women to raise with their doctors at their next appointment. It is not a diagnostic tool but rather provides a starting point for discussion with a medical professional. Users can opt to share their information anonymously as part of a wider database researchers can use to develop new medications and treatments or better understand conditions. With access to sensitive personal data, Dr Heffernan-Marks says Ovum is nationally and globally compliant with stringent standards to protect users. "Ovum is really about addressing the structural, integrated and research barriers ... we have decades (of medical research) to catch up on and AI will help us do that," she says. "We are creating a safe space for women and solving the health data gap by feeding information back into the research." Women are taking control of their health with a game-changing artificial intelligence tool to help navigate a medical system that has historically gaslit, dismissed and ignored their symptoms. More than half of Australian women live with a chronic health condition and wait years to be diagnosed, often as a result of being dismissed by health professionals. Mary Spanos first started experiencing painful symptoms of endometriosis when she was 12 years old but was not officially diagnosed until she was in her 20s. "It's a ridiculously long time to be experiencing those debilitating symptoms and there were countless emergency room visits and specialist appointments where I was completely dismissed," she tells AAP. Ms Spanos is one of countless women who have suffered in silence. "I honestly thought it was all in my head and had so many negative thoughts because the people who were supposed to know what was going on medically were telling me it was fine," she says. It's a similar story for Grace Lam, who started to experience debilitating health symptoms as she approached 50. A former senior fashion editor of Vogue China, Ms Lam was used to thriving in fast-paced, high-powered environments. Yet seemingly overnight, she began to experience insomnia, low libido, extreme brain fog and driving anxiety. "My symptoms hit me like a rocket overnight ... it felt like every day my brain was outside my body and I would wake up feeling so strange," Ms Lam says. "The rage was also something else. I am a feisty Asian woman, so that's nothing new, but this type of rage was just very different." When she raised these symptoms with her GP, the doctor prescribed her sleeping pills but would not discuss any management plans for perimenopause. "I didn't want to rely on the sleeping pills, so that's when I went down the rabbit hole of perimenopause symptoms online," Ms Lam says. "I learnt more about perimenopause online than from my doctor." A newly launched AI health partner Ovum wants to disrupt the health landscape and end gender health inequity across Australia. The app has been four years in the making, with two clinical trials at The Royal Hospital for Women and St George Hospital. It was founded by Ariella Heffernan-Marks, who had the idea while training as a doctor and witnessing the healthcare issues facing women. "I observed the structural barriers in our health care and realised we needed to look at integrated data rather than having it spread across multiple physicians and specialists," she says. "Women are feeling the bias in the healthcare system ... they have not been included in clinical trials for decades and this is impacting diagnostics and treatment." After suffering chronic migraines during medical school, Dr Heffernan-Marks personally experienced being dismissed by specialists and decided something needed to change. "We need to redefine women's health to not just be about reproductive health because there are so many chronic conditions facing women," she says. "All the fem-tech tools on the market are not catering to what women actually need." The AI behind Ovum draws from female-centric medical literature to understand and learn from a wide range of health factors. It helps identify patterns, log symptoms, collate reports and create questions for women to raise with their doctors at their next appointment. It is not a diagnostic tool but rather provides a starting point for discussion with a medical professional. Users can opt to share their information anonymously as part of a wider database researchers can use to develop new medications and treatments or better understand conditions. With access to sensitive personal data, Dr Heffernan-Marks says Ovum is nationally and globally compliant with stringent standards to protect users. "Ovum is really about addressing the structural, integrated and research barriers ... we have decades (of medical research) to catch up on and AI will help us do that," she says. "We are creating a safe space for women and solving the health data gap by feeding information back into the research." Women are taking control of their health with a game-changing artificial intelligence tool to help navigate a medical system that has historically gaslit, dismissed and ignored their symptoms. More than half of Australian women live with a chronic health condition and wait years to be diagnosed, often as a result of being dismissed by health professionals. Mary Spanos first started experiencing painful symptoms of endometriosis when she was 12 years old but was not officially diagnosed until she was in her 20s. "It's a ridiculously long time to be experiencing those debilitating symptoms and there were countless emergency room visits and specialist appointments where I was completely dismissed," she tells AAP. Ms Spanos is one of countless women who have suffered in silence. "I honestly thought it was all in my head and had so many negative thoughts because the people who were supposed to know what was going on medically were telling me it was fine," she says. It's a similar story for Grace Lam, who started to experience debilitating health symptoms as she approached 50. A former senior fashion editor of Vogue China, Ms Lam was used to thriving in fast-paced, high-powered environments. Yet seemingly overnight, she began to experience insomnia, low libido, extreme brain fog and driving anxiety. "My symptoms hit me like a rocket overnight ... it felt like every day my brain was outside my body and I would wake up feeling so strange," Ms Lam says. "The rage was also something else. I am a feisty Asian woman, so that's nothing new, but this type of rage was just very different." When she raised these symptoms with her GP, the doctor prescribed her sleeping pills but would not discuss any management plans for perimenopause. "I didn't want to rely on the sleeping pills, so that's when I went down the rabbit hole of perimenopause symptoms online," Ms Lam says. "I learnt more about perimenopause online than from my doctor." A newly launched AI health partner Ovum wants to disrupt the health landscape and end gender health inequity across Australia. The app has been four years in the making, with two clinical trials at The Royal Hospital for Women and St George Hospital. It was founded by Ariella Heffernan-Marks, who had the idea while training as a doctor and witnessing the healthcare issues facing women. "I observed the structural barriers in our health care and realised we needed to look at integrated data rather than having it spread across multiple physicians and specialists," she says. "Women are feeling the bias in the healthcare system ... they have not been included in clinical trials for decades and this is impacting diagnostics and treatment." After suffering chronic migraines during medical school, Dr Heffernan-Marks personally experienced being dismissed by specialists and decided something needed to change. "We need to redefine women's health to not just be about reproductive health because there are so many chronic conditions facing women," she says. "All the fem-tech tools on the market are not catering to what women actually need." The AI behind Ovum draws from female-centric medical literature to understand and learn from a wide range of health factors. It helps identify patterns, log symptoms, collate reports and create questions for women to raise with their doctors at their next appointment. It is not a diagnostic tool but rather provides a starting point for discussion with a medical professional. Users can opt to share their information anonymously as part of a wider database researchers can use to develop new medications and treatments or better understand conditions. With access to sensitive personal data, Dr Heffernan-Marks says Ovum is nationally and globally compliant with stringent standards to protect users. "Ovum is really about addressing the structural, integrated and research barriers ... we have decades (of medical research) to catch up on and AI will help us do that," she says. "We are creating a safe space for women and solving the health data gap by feeding information back into the research."
Sky News AU
20 hours ago
- Sky News AU
'It pulled me out of the darkness': Channel 10's Barry Du Bois says the words 'I'm not okay' helped save his life, and could save countless others
Barry Du Bois has weathered more storms than most- the death of his mother, a debilitating back injury, years of unsuccessful IVF, the loss of a pregnancy, his wife Leonie's cervical cancer diagnosis, and his own battle with an incurable blood cancer. But Channel 10's The Living Room co-host says one of the most important lessons he's learned through it all is the power of a few simple words: "I'm not okay." "My mental health unravelled after those years of heartbreak," Du Bois told "I spiralled into a very lonely, low place. I even contemplated ending my life. But a friend encouraged me to open up - and that conversation pulled me back." At 65 years old, Du Bois is living with multiple myeloma, a rare and incurable type of blood cancer. He was initially diagnosed in 2010 with solitary plasmacytoma, another rare form of blood cancer. This diagnosis progressed to myeloma in 2017, a condition that impacts the immune system while attacking the bone marrow. Eight years later, he continues to defy the odds, and he's using his platform to inspire others to speak up before they hit crisis point. "I know personally, when you realise that people will support you, that's when your journey out of that darkness starts to happen," he said. That philosophy is why Du Bois has joined the Heart on My Sleeve "I'm Not Okay" campaign, founded by mental health advocate Mitch Wallis. The initiative urges Australians not to wait to be asked if they're struggling. Instead, they're encouraged to put their heart on their sleeve, literally, and say it out loud. Alongside Du Bois, the campaign's ambassador line-up includes world champion surfer Layne Beachley, TV host David Koch, NRL star Kieran Foran, actor Sharon Johal, ironman Guy Leech, Gogglebox's Jad Nehmetallah, entertainment reporter Richard Reid and journalist Antoinette Lattouf. The father-of-two, who is also a proud ambassador and board member of R U OK? Day, said his work with Heart on My Sleeve is "incredibly complementary". "I think (the campaign) really complements what I do at R U OK? Day," he said. "One encourages people to check in on their loved ones and the other encourages people to speak up. Really, it's all about strengthening society and understanding the value of emotion, the positive and the negative, and not being afraid to share the tough stuff." Du Bois admitted that was not something he learned growing up. "I was raised not to show your emotions, and that took me to a very, very dark place," he said. "So now I'm incredibly passionate about telling people that they can be brave enough to show their emotions." As the proud father of 13-year-old twins, Bennett and Arabella, he's determined they'll always feel "heard". "So many children, in the busy lives that we have today, don't feel heard by their parents," he said. "The first reason is that parents often… speak in a solution-based conversation. "They see that there's a problem and the parent wants to solve it. "And when you've got a child that craves autonomy or craves independence… You telling them what they should do doesn't help." Instead, he says, parents should create conversations "where you're both learning something". Without that, kids may look elsewhere, often to social media, for validation and connection. From his own experience, Du Bois knows that perspective matters- not just for kids, but for carers. Supporting Leonie through her cancer battle gave him a new understanding of the toll it can take. "When you're a carer, you're going through something that's called borrowed trauma," he said. "You're dealing with the trauma of others as well as your own trauma, and it's really important to make sure that we get some reprieve from that. "We have to make sure our personal cup of empathy is full. We need to care for ourselves so that we can care for others." Looking back, he admits: "I refused to share the emotion and pain I was in. I sort of resented caring for myself because I believed others needed it more. But that's just not a balanced way to think." And for those facing their own illness or cancer battle, Du Bois has a simple message. "So often in this world, particularly in the medical industry, they do give up as a number, but we're not," he said. "Never give up believing there's an opportunity to do better. "Be curious about every possibility there is- new treatments, lifestyle changes, support networks. We're not defined by the diagnosis we have today, but by how we get up and thrive after it." For Du Bois, joining I'm Not Okay is another step in what he calls putting "grains of sand" in front of the wrecking ball of mental ill-health- small but vital acts of advocacy and connection. "I believe, as a modern day elder (that's how I describe myself these days) it's our duty to be as curious and to be as aware on how we can how it can improve society and how we can strengthen society," said. "Because if we're vigilant to constantly change for the better society, that means my children will have a place where they'll be able to thrive and where they will have their best opportunities."
